Contributors

Aaron Varghese, MD
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA

Amma F. Agyemang, MD, PHD
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Annika M Bruger, PHD
TILS group, De Duve Institute, UCLouvain, Brussels, Belgium

Bárbara da Silva Martins
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil

Bawinile Hadebe, MD
Department of Nuclear Medicine, University of KwaZulu-Natal, Durban, South Africa

Diana Nunes, MSC
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal/Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal

Jean-Francois Baurain, MD, PHD
Gynaecological oncology board, Institut Roi Albert II, Cliniques universitaires Saint Luc, UCLouvain, Brussels, Belgium

Jean-Luc Squifflet, MD, PHD
Gynaecological oncology board, Institut Roi Albert II, Cliniques universitaires Saint Luc, UCLouvain, Brussels, Belgium

Josiany Carlos de Souza, MSC
Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil

Leticia Batista Azevedo Rangel, PHARMD, PHD
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil

Mariana Nunes, MSC
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal/Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal

Mariza Vorster, MD, PHD
Department of Nuclear Medicine, University of KwaZulu-Natal, Durban, South Africa

Mathieu Luyckx, MD
Gynaecological oncology board, Institut Roi Albert II, Cliniques universitaires Saint Luc, UCLouvain, Brussels, Belgium

Roberto Silva Ribeiro Junior
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil

Sara Ricardo, PHD
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal/Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal

Shashikant Lele, MD
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA

Tatiana Massariol Pimenta
Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, ES, Brazil

Venesen Pillay, MD
Department of Nuclear Medicine, University of KwaZulu-Natal, Durban, South Africa